|
Volumn 36, Issue 6, 2007, Pages 464-469
|
Considerations not only on angiogenesis inhibitors. Pharmacoeconomics: Curse or blessing for medical care?;Überlegungen nicht nur zu angiogenese-hemmern. Pharmakoökonomie: Fluch oder segen für die medizinische versorgung?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS;
ARTICLE;
COST EFFECTIVENESS ANALYSIS;
ECONOMIC EVALUATION;
HEALTH PROGRAM;
MEDICAL CARE;
QUALITY ADJUSTED LIFE YEAR;
STANDARD;
ECONOMICS;
HUMAN;
PHARMACOECONOMICS;
REVIEW;
ANGIOGENESIS INHIBITOR;
ANGIOGENESIS INHIBITORS;
ECONOMICS, PHARMACEUTICAL;
HUMANS;
|
EID: 36348988573
PISSN: 00483664
EISSN: 16151003
Source Type: Journal
DOI: 10.1002/pauz.200700244 Document Type: Article |
Times cited : (1)
|
References (6)
|